Pregnancy News and Research

Latest Pregnancy News and Research

Workshop to address high-risk adolescent behaviors

The Evolution Institute and the University of Arizona's Frances McClelland Institute for Children, Youth, and Families are co-hosting an invitation-only workshop at the university, Oct. 30 - Nov. 2, for world-renowned scholars who will apply evolutionary theory to the development of practical solutions for high-risk adolescent behaviors plaguing Western societies.

17 Sep 2009

UPV provides new model to recognize postnatal depression

Worldwide, 13% of women who give birth suffer from postnatal depression, which causes a significant deterioration in a mother's quality of life and her ability to care for her baby. Now, Spanish researchers have developed a model to diagnose this illness with a predictive power of 80% - the best result to date for this kind of depression.

17 Sep 2009

Models of care developed by nurses discussed at a briefing on health care reform

Two innovative and highly successful models of care developed by nurses were the centerpiece of a briefing today on health care reform. The event, which brought together women's health leaders and health care experts, focused on the ways in which innovative health care models can help to improve efficiency, reduce costs and ensure quality care for patients and their families.

17 Sep 2009

Findings may lead to drugs that destroy TB in dormant stage of lifecycle

Attempts to eradicate tuberculosis (TB) are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells. Now, a team of scientists led by researchers from Weill Cornell Medical College has identified compounds that inhibit that mechanism -- without damaging human cells.

17 Sep 2009

Nuveta closes Series A seed financing round for in vitro fertilization research

Nuveta, Inc., a privately held medical device company and global leader in basic in vitro fertilization (IVF) research, announced today that it has closed a Series A seed financing round, solely funded by Vivo Ventures.

17 Sep 2009

Teva announces availability of its Plan B One-Step emergency contraceptive over-the-counter

Teva Women’s Health, Inc. announced today that its Plan B® One-Step (levonorgestrel) tablet, 1.5 mg emergency contraceptive is now available at licensed U.S. retail pharmacies. Approved by the U.S. Food and Drug Administration (FDA) on July 10, Plan B® One-Step can help prevent an unintended pregnancy after unprotected sex or contraceptive failure with just one pill in one dose.

16 Sep 2009

Newly developed model helps early diagnosis of postnatal depression

16 Sep 2009

Phase II VICTOR-E1 clinical study results reported

Schering-Plough Corporation today reported long-term data with vicriviroc, its investigational CCR5 receptor antagonist, from an ongoing, open-label extension of the Phase II VICTOR-E1 study in treatment-experienced HIV-infected patients.

15 Sep 2009

Prenatal testing helps to bring down the birth rate of babies with Down syndrome

With new prenatal tests for Down syndrome on the horizon promising to be safer, more accurate, and available to women earlier in pregnancy, the medical community must come together and engage in dialogue about the impact of existing and expected tests, argues a new leading article published Online First by Archives of Disease in Childhood.

14 Sep 2009

Phase III STARTMRK clinical study on ISENTRESS in comparison to efavirenz

ISENTRESS , an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell counts in previously untreated (treatment-naïve) HIV-1-infected patients through 96 weeks in a Phase III study called STARTMRK.

14 Sep 2009

FDA approves Theravance's VIBATIV for treating complicated skin and skin structure infections

Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.

14 Sep 2009

U.S., Australian researchers say single H1N1 vaccine dose protects adults against virus

The results of clinical trials have shown one dose of the H1N1 (swine) flu vaccine is enough to offer adults protection against the virus, U.S. and Australian researchers said Thursday, the Associated Press reports (Neergaard, 9/11).

11 Sep 2009

Study identifies causes, rates of death among young people worldwide

"Road accidents, pregnancy and childbirth complications, suicide, violence, the AIDS virus and tuberculosis are the biggest killers of young people across the world," according to a paper published on Friday in the journal Lancet, Reuters reports.

11 Sep 2009

Quidel Corporation expects highest quarterly revenue due to brisk sales of flu tests

Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care diagnostic tests, announced today that it currently anticipates its highest quarterly revenue and operating income in its history, driven by global shipments of its QuickVue® Influenza A+B tests in the third quarter of 2009.

11 Sep 2009

Merck update on the status of telcagepant clinical development programs

Merck & Co., Inc. today updated the status of the clinical development programs for telcagepant (MK-0974) and MK-3207, the Company's investigational oral calcitonin gene-related peptide (CGRP) receptor antagonists for the intermittent treatment of acute migraine.

11 Sep 2009

Routine screening is useful for identifying pregnant women with gestational diabetes

Pregnant women who develop marked increased blood sugar levels during pregnancy can reduce the risk of certain birth complications if they receive treatment. This is a prerequisite for offering all pregnant women routine screening for gestational diabetes.

11 Sep 2009

FDA approves Supplemental New Drug Application for DOXIL

Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for DOXIL (doxorubicin HCI liposome injection) in combination with docetaxel for the treatment of women with locally advanced and metastatic breast cancer.

10 Sep 2009

New protocol to tackle postpartum depression

Up to 80 percent of women experience depressive symptoms postpartum, with one in eight reporting the emergence of major depression within weeks of delivery.

10 Sep 2009

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

In 2008, the global anti-aging skincare market approached $15 billion, with 32 percent of U.S. facial skincare product launches boasting anti-aging claims many over-the-counter products are claiming to achieve comparable benefits as prescription anti-aging treatments.

10 Sep 2009

First trial of 2009 H1N1 influenza vaccine testing launched

The first trial testing a candidate 2009 H1N1 influenza vaccine in pregnant women is launching this week, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today.

10 Sep 2009

Pregnancy News and Research

Latest Pregnancy News and Research

Workshop to address high-risk adolescent behaviors

UPV provides new model to recognize postnatal depression

Models of care developed by nurses discussed at a briefing on health care reform

Findings may lead to drugs that destroy TB in dormant stage of lifecycle

Nuveta closes Series A seed financing round for in vitro fertilization research

Teva announces availability of its Plan B One-Step emergency contraceptive over-the-counter

Newly developed model helps early diagnosis of postnatal depression

Phase II VICTOR-E1 clinical study results reported

Prenatal testing helps to bring down the birth rate of babies with Down syndrome

Phase III STARTMRK clinical study on ISENTRESS in comparison to efavirenz

FDA approves Theravance's VIBATIV for treating complicated skin and skin structure infections

U.S., Australian researchers say single H1N1 vaccine dose protects adults against virus

Study identifies causes, rates of death among young people worldwide

Quidel Corporation expects highest quarterly revenue due to brisk sales of flu tests

Merck update on the status of telcagepant clinical development programs

Routine screening is useful for identifying pregnant women with gestational diabetes

FDA approves Supplemental New Drug Application for DOXIL

New protocol to tackle postpartum depression

Clinical trial reveals RENOVA topical treatment cream shows continuous improvement

First trial of 2009 H1N1 influenza vaccine testing launched

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pregnancy News and Research

Latest Pregnancy News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in